Tag
The article discusses the difficulties in purchasing gray market peptides due to AI-generated fake websites and reviews, which mimic legitimate platforms like TrustPilot to deceive consumers.
The FDA is set to discuss reclassifying peptides for compounding, with telehealth companies like Mochi Health and Hims & Hers preparing to cash in on the anticipated regulatory shift, driven by political influence from HHS Secretary RFK Jr. and the GLP-1 boom.
Researchers at the Technical University of Denmark used a hybrid AI and quantum computing approach to generate novel peptides that bind to specific proteins, showing improved performance especially with sparse data, potentially accelerating vaccine and personalized immunotherapy development.
CAPABLE is an AI-driven lab that can go from drug design to data in 24 hours, starting with short-sleeper peptides. The project aims to turn AI capabilities into human capabilities for drug development.
This WIRED security news roundup covers Meta's dormant face-recognition code, xAI's legal battle over deepfake nudes, Google's anti-scam Android feature, and a highlight on crypto-funded Chinese labs selling peptides.
Huberman Lab podcast episode featuring Dr. Abud Bakri discussing the science, uses, and safety of peptides, including BPC-157, with a focus on regeneration and animal data.